Interleukin-1β Regulates Angiopoietin-1 Expression in Human Endothelial Cells
Open Access
- 1 May 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (9) , 3186-3190
- https://doi.org/10.1158/0008-5472.can-03-0407
Abstract
Angiopoietin (Ang)-1 is an important regulator of endothelial cell (EC) survival and stabilization. Ang-1 exerts its biological effects by binding to the EC-specific tyrosine kinase receptor Tie-2, and initiates intracellular signaling in ECs. However, regulatory mechanisms for endothelial Ang-1 expression have not been completely elucidated. In this study, we investigated the effects of angiogenic cytokines and growth factors on Ang-1 expression in human umbilical vein ECs (HUVECs). Northern blot analysis was performed after HUVECs were exposed to interleukin-1β (IL-1β), tumor necrosis factor-α, platelet-derived growth factor-BB, insulin-like growth factor-1, or vascular endothelial growth factor (VEGF). Both IL-1β and tumor necrosis factor-α caused marked down-regulation of Ang-1 mRNA levels at 4 h with a further decrease observed at 24 h. Using signaling inhibitors, we identified the P38 pathway as the pathway that mediates IL-1β down-regulation of Ang-1. Furthermore, treatment of cells with IL-1β indirectly (via down-regulation of Ang-1) led to a decrease in Tie-2 autophosphorylation levels in HUVECs. We previously demonstrated that IL-1β regulates VEGF expression in tumor cells. This observation was confirmed in ECs in the present study. Because pericytes play a role in regulating EC function, we also determined whether IL-1β would also down-regulate Ang-1 in human vascular smooth muscle cells. Similar to our findings in HUVECs, we found that IL-1β decreased Ang-1 expression in human vascular smooth muscle cells. Direct effects of IL-1β on angiogenesis were investigated by use of an in vivo Gelfoam angiogenesis assay in which IL-1β produced a significant increase in vessel counts (P = 0.0189). These results suggest that IL-1β indirectly regulates angiogenesis by modulating the expression of Ang-1. IL-1β may trigger a proangiogenic response by decreasing Ang-1 levels in ECs and pericytes and up-regulating VEGF in ECs and tumor cells.Keywords
This publication has 22 references indexed in Scilit:
- Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor αAnnals of the Rheumatic Diseases, 2003
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implicationsSeminars in Oncology, 2002
- Rheumatoid arthritis: developing pharmacological therapiesExpert Opinion on Investigational Drugs, 2002
- Inflammatory Cytokines, Angiogenesis, and Fibrosis in the Rat PeritoneumThe American Journal of Pathology, 2002
- ROLE OF P38 MAPK, AP-1, AND NF-κB IN INTERLEUKIN-1β-INDUCED IL-8 EXPRESSION IN HUMAN VASCULAR SMOOTH MUSCLE CELLSCytokine, 2002
- Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma GrowthPublished by Elsevier ,2002
- Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial CellsJournal of Biological Chemistry, 2001
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Interleukin-1 Upregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine KinasesJournal of Molecular and Cellular Cardiology, 1999